| Niloy Dasgupta, MD | |
|
640 S State St, Dover, DE 19901-3530 | |
| (302) 674-4700 | |
| Not Available |
| Full Name | Niloy Dasgupta |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 640 S State St, Dover, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215170972 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Bayhealth Hospital, Sussex Campus | Milford, DE | Hospital |
| Western Maryland Regional Medical Center | Cumberland, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kent Diagnostic Radiology Associates Pa | 3971591371 | 46 |
News Archive
According to a recent study, intrauterine devices (IUDs) used by women for contraception might lower the risk of getting cervix cancer compared to women who do not use this form of contraception. The review titled, "Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis" from the Keck School of Medicine of USC appeared in the online November issue of Obstetrics & Gynecology.
On World AIDS Day 2007, hundreds, perhaps thousands, of men who have sex with men (MSM) will become infected with HIV in cities across the Asia Pacific, becoming the latest statistics in an almost unrecognized but ever-growing crisis that many governments in the region are only just beginning to grapple with.
Scientists from Tibotec Pharmaceuticals Ltd. presented data on several new compounds for the treatment of HIV/AIDS at the 12th Conference on Retroviruses and Opportunistic Infections (CROI), held February 22-25 in Boston, MA, USA.
Thanks to a $1.2 million grant from the Swedish International Development Cooperation Agency (SIDA), a York University-based group of international researchers are pressing ahead with plans to develop a system for monitoring and promoting human rights for people with disabilities around the world.
The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.
› Verified 2 days ago
| Entity Name | Kent Diagnostic Radiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417044298 PECOS PAC ID: 3971591371 Enrollment ID: O20040504001264 |
News Archive
According to a recent study, intrauterine devices (IUDs) used by women for contraception might lower the risk of getting cervix cancer compared to women who do not use this form of contraception. The review titled, "Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis" from the Keck School of Medicine of USC appeared in the online November issue of Obstetrics & Gynecology.
On World AIDS Day 2007, hundreds, perhaps thousands, of men who have sex with men (MSM) will become infected with HIV in cities across the Asia Pacific, becoming the latest statistics in an almost unrecognized but ever-growing crisis that many governments in the region are only just beginning to grapple with.
Scientists from Tibotec Pharmaceuticals Ltd. presented data on several new compounds for the treatment of HIV/AIDS at the 12th Conference on Retroviruses and Opportunistic Infections (CROI), held February 22-25 in Boston, MA, USA.
Thanks to a $1.2 million grant from the Swedish International Development Cooperation Agency (SIDA), a York University-based group of international researchers are pressing ahead with plans to develop a system for monitoring and promoting human rights for people with disabilities around the world.
The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Niloy Dasgupta, MD 723 Brandywine Dr, Bear, DE 19701-1274 Ph: (571) 265-9715 | Niloy Dasgupta, MD 640 S State St, Dover, DE 19901-3530 Ph: (302) 674-4700 |
News Archive
According to a recent study, intrauterine devices (IUDs) used by women for contraception might lower the risk of getting cervix cancer compared to women who do not use this form of contraception. The review titled, "Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis" from the Keck School of Medicine of USC appeared in the online November issue of Obstetrics & Gynecology.
On World AIDS Day 2007, hundreds, perhaps thousands, of men who have sex with men (MSM) will become infected with HIV in cities across the Asia Pacific, becoming the latest statistics in an almost unrecognized but ever-growing crisis that many governments in the region are only just beginning to grapple with.
Scientists from Tibotec Pharmaceuticals Ltd. presented data on several new compounds for the treatment of HIV/AIDS at the 12th Conference on Retroviruses and Opportunistic Infections (CROI), held February 22-25 in Boston, MA, USA.
Thanks to a $1.2 million grant from the Swedish International Development Cooperation Agency (SIDA), a York University-based group of international researchers are pressing ahead with plans to develop a system for monitoring and promoting human rights for people with disabilities around the world.
The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.
› Verified 2 days ago
Geh Meh Chu, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7062 | |
Dr. Michael A Amygdalos, Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 S State Street, Dept Of Radiology, Dover, DE 19901 Phone: 302-674-2202 | |
Michael F Polise, D.O Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 S State Street, Dept Of Radiology, Dover, DE 19901 Phone: 302-674-2202 | |
Rachel Taylor, Radiology Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7062 | |
James Mezger, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-480-1688 Fax: 302-480-9807 | |
Dr. Martin G Begley, Radiology Medicare: Not Enrolled in Medicare Practice Location: 640 S State Street, Dept Of Radiology, Dover, DE 19901 Phone: 302-674-2202 | |
Thomas E Vaughan, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7062 Fax: 302-744-6215 |